author-photo

Jun-min Li

Ruijin Hospital

10

Papers

44

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (5)
The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.

2012 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (36)
Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in Patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group

2011 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Activation of PI3K/Akt/mTOR Pathway in Diffuse Large B-Cell Lymphomas: Clinical Significance and Inhibitory Effect by Rituximab.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Outcome of Imatinib Treatment in Chronic Myeloid Leukemia (CML) Patients in Shanghai: An International Patient Assistance Programs (GIPAP) Analysis.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Fludarabine-Based Regimens in the Treatment of Indolent Non-Hodgkin’s Lymphoma Patients: A Clinical Study of the Fludarabine Cooperation Group in 16 Hospitals in Eastern China.

2005 Blood
- Jun-min Li
Show All
- Source
- Cite
- Save
Citations (1)
Study of Sequential Treatment of Newly Diagnosed De Novo AML Patients with DA and CAG Regimens as Remission Induction Therapy.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A 3-Year Follow-Up of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (As 2 O 3 ) as Front Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia (APL).

2005 Blood
Show All
- Source
- Cite
- Save
Citations (0)